3 exciting ASX healthcare shares to buy in May

CSL Limited (ASX:CSL) and these ASX healthcare shares could be worth considering in May. Here's why I like them…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Due to a number of positive tailwinds including increased chronic disease burden and ageing populations, I believe the healthcare sector is one of the best places to invest your money with a long term view.

And the good news is that there's no shortage of options in the space for investors to choose from.

With that in mind, here are three options in the sector to consider:

Alcidion Group Ltd (ASX: ALC)

If you're interested in small cap shares then you might want to take a look at Alcidion. It is a fast-growing health informatics company which is aiming to transform healthcare with smart, intuitive technology solutions. It has a growing portfolio of software products and services that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes.

CSL Limited (ASX: CSL)

And at the big end of the market you'll find this global biotherapeutics company. I believe CSL is the highest quality company Australia has to offer and capable of generating strong returns for investors over the long term. Especially given its leading therapies, lucrative plasma collection network, and its research and development pipeline. The latter is underpinned by high level of investment each year by the company. For example, in FY 2019 CSL invested a massive US$832 million in R&D activities across its businesses.

ResMed Inc. (ASX: RMD)

Finally, I think ResMed is another healthcare share to consider with a long term view. This medical device company has been growing at a very strong rate over the last few years thanks to its sleep treatment business. The proliferation of sleep apnoea has been driving very strong demand for both its hardware and its software. Given how many people globally are believed to be undiagnosed sufferers of sleep apnoea, I believe ResMed has a significant runway for growth. Though, with its third quarter update due to be released tomorrow, it might be prudent to wait for that before investing.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd and CSL Ltd. The Motley Fool Australia has recommended Alcidion Group Ltd and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A smiling woman holds a Facebook like sign above her head.
Growth Shares

ResMed is an ASX share market success story that deserves your attention

This ASX share has made many investors wealthy over the past decade.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Growth Shares

Meet the $3 ASX stock that's forecast to smash CBA shares over the next 12 months

This ASX share is rated as a much better buy than CBA.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

2 high-quality ASX 200 stocks this fund manager is bullish about

These businesses have a compelling future.

Read more »

A smiling little boy helps his father plant a tree, indicating that big things grow from a small beginning.
Growth Shares

2 ASX shares to buy and hold for the next decade

I reckon these businesses have strong growth outlooks.

Read more »

Happy young Asian business woman with her for corporate associates.
Growth Shares

Buy these 2 impressive ASX shares in August: experts

These stocks have appealing valuations according to leading analysts.

Read more »

RIO BHP Profit upgrade A business man open his shirt to reveal a superhero style $ on his chest, indicating a strong ASX share price
Growth Shares

3 fantastic ASX 200 growth shares to buy with $2,000 in August

Do you have money to put into the market? Here are three shares analysts are bullish on.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Growth Shares

Zip shares are a buy – UBS

The buy now, pay later business has a few positives.

Read more »

A couple are happy sitting on their yacht.
Growth Shares

2 Australian stocks that could turn $15k into $150k

Analysts think these stocks are buys. Here's why they could be great long term picks.

Read more »